Sections
Title | Starting Page | Number of Pages |
---|
Table of Contents | 2 | 4 |
List of Tables | 4 | 1 |
List of Figures | 5 | 1 |
AMAG Pharmaceuticals, Inc., Medical Equipment, Deals By Year, 2010 to YTD 2016 | 5 | 2 |
AMAG Pharmaceuticals, Inc., Medical Equipment Deals By Type, 2010 to YTD 2016 | 7 | 1 |
AMAG Pharmaceuticals, Inc., Medical Equipment, Deals By Region, 2010 to YTD 2016 | 8 | 1 |
AMAG Pharmaceuticals, Inc., Medical Equipment, Deals By Market, 2010 to YTD 2016 | 9 | 1 |
AMAG Pharmaceuticals, Inc., Medical Equipment, Deals Summary, 2010 to YTD 2016 | 10 | 1 |
AMAG Pharmaceuticals, Inc., Medical Equipment, Deal Details | 11 | 13 |
Private Equity | 11 | 1 |
MSMB Capital Management To Acquire AMAG Pharma | 11 | 1 |
Partnerships | 12 | 1 |
Cesca Therapeutics Amends Licensing Agreement with CBR Systems | 12 | 1 |
Access Pharma Enters Into Licensing Agreement With Amag Pharma For MuGard | 13 | 2 |
Equity Offering | 15 | 1 |
AMAG Pharma Raises USD231 Million in Public Offering of Shares | 15 | 2 |
Amag Pharma Files Registration Statement For Public Offering Of Securities For Up To US$250 Million | 17 | 1 |
AMAG Pharma Completes Public Offering Of US$174 Million | 18 | 2 |
Debt Offering | 20 | 1 |
AMAG Pharma Raises USD500 Million in Private Placement of 7.878% Notes Due 2023 | 20 | 1 |
Amag Pharma Completes Public Offering Of Notes Due 2019 For US$200 Million | 21 | 2 |
Acquisition | 23 | 1 |
AMAG Pharma Plans For Sale Of The Company | 23 | 1 |
AMAG Pharmaceuticals, Inc. - Key Competitors | 24 | 1 |
Key Employees | 25 | 2 |
Locations And Subsidiaries | 27 | 1 |
Head Office | 27 | 1 |
Other Locations &Subsidiaries | 27 | 1 |
Recent Developments | 28 | 1 |
Financial Announcements | 28 | 1 |
Aug 09, 2016: AMAG Pharmaceuticals Reports Second Quarter 2016 Financial Results and Provides Corporate Update | 28 | 3 |
May 03, 2016: AMAG Pharmaceuticals Reports First Quarter 2016 Financial Results | 31 | 2 |
Feb 17, 2016: AMAG Pharmaceuticals Reports Fourth Quarter and Full Year 2015 Financial Results | 33 | 2 |
Jul 23, 2015: AMAG Pharmaceuticals Reports Record Second Quarter 2015 Financial Results | 35 | 2 |
May 05, 2015: AMAG Pharmaceuticals Reports Record First Quarter 2015 Financial Results and Increases Financial Guidance | 37 | 2 |
Feb 09, 2015: AMAG Announces Final Fourth Quarter and Year End 2014 Financial Results | 39 | 2 |
Jan 11, 2015: AMAG Pharmaceuticals Provides Business Update and 2015 Financial Guidance | 41 | 2 |
Corporate Communications | 43 | 1 |
Sep 07, 2016: AMAG Pharmaceuticals Appoints Tony Casciano as Senior Vice President of Hematology/Oncology Sales and Marketing | 43 | 1 |
Jul 12, 2016: AMAG Pharmaceuticals Appoints Mark Stanton as Vice President, Market Access &Corporate Accounts | 44 | 1 |
Apr 11, 2016: AMAG Pharmaceuticals Appoints Edward Myles as Chief Financial Officer | 45 | 1 |
Jan 04, 2016: AMAG Pharmaceuticals Appoints Nicholas Grund as Chief Commercial Officer | 46 | 1 |
Aug 24, 2015: AMAG Pharmaceuticals Appoints Joseph Vittiglio as General Counsel and Secretary | 47 | 1 |
Jun 09, 2015: AMAG Pharmaceuticals Appoints Aaron Pelta as Vice President of Business Development | 48 | 1 |
Jun 02, 2015: AMAG Pharmaceuticals Announces New Senior Management Appointments | 49 | 1 |
Apr 01, 2015: AMAG Pharmaceuticals Announces New Management Appointments | 50 | 1 |
Other Significant Developments | 51 | 1 |
Jul 15, 2016: PhRMA Welcomes Five New Member Companies | 51 | 1 |
Jan 11, 2016: AMAG Pharmaceuticals Announces Preliminary 2015 Financial Results and Provides 2016 Financial Guidance | 52 | 1 |
Appendix | 53 | 1 |
Methodology | 53 | 1 |
About GlobalData | 53 | 1 |
Contact Us | 53 | 1 |
Disclaimer | 53 | 1 |